Carregant...
Advancing Trial Design in Progressive Multiple Sclerosis
The failure of a majority of clinical trials in progressive MS has highlighted the need to reconsider how these trials are designed and conducted, and many areas deserve focus. Basic scientists are reconceptualising the pathophysiology of progressive MS into three broad areas: systemic inflammation,...
Guardat en:
| Publicat a: | Mult Scler |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5714314/ https://ncbi.nlm.nih.gov/pubmed/29041871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517729768 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|